Elena Arturovna Mukhlynina

Dr. Elena Arturovna Mukhlynina

Institute of Immunology and Physiology, Yekaterinburg, Sverdlovskaya Oblast’, Russia
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Functional Foods
Verified
Journal Article
Open access
KDKingsley C. Duru
Kingsley C. Duru
Elena Arturovna MukhlyninaElena Arturovna Mukhlynina
Elena Arturovna Mukhlynina
GMGleb. A. Moroz
Gleb. A. Moroz
IGIrina F. Gette
Irina F. Gette
IDIrina G. Danilova
Irina G. Danilova
EKElena G. Kovaleva
Elena G. Kovaleva

14 January 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
EDEkaterina Demicheva
Ekaterina Demicheva
Vladislav DordiukVladislav Dordiuk
Vladislav Dordiuk
FEFernando Jonathan Polanco Espino
Fernando Jonathan Polanco Espino
KUKonstantin Ushenin
Konstantin Ushenin
SASaied A Aboushanab
Saied A Aboushanab
EKElena Germanovna Kovaleva
Elena Germanovna Kovaleva
Blood metabolomics profiling using mass spectrometry has emerged as a powerful approach for investigating non-cancer diseases and understanding their underlying metabolic alterations. Blood, as a readily accessible physiological fluid, contains a diverse repertoire of metabolites derived from various physiological systems. Mass spectrometry offers a universal and precise analytical platform for the comprehensive analysis of blood metabolites, encompassing proteins, lipids, peptides, glycans, and immunoglobulins. In this comprehensive review, we present an overview of the research landscape in mass spectrometry-based blood metabolomics profiling. While the field of metabolomics research is primarily focused on cancer, this review specifically highlights studies related to non-cancer diseases, aiming to bring attention to valuable research that often remains overshadowed. Employing natural language processing methods, we processed 507 articles to provide insights into the application of metabolomic studies for specific diseases and physiological systems. The review encompasses a wide range of non-cancer diseases, with emphasis on cardiovascular disease, reproductive disease, diabetes, inflammation, and immunodeficiency states. By analyzing blood samples, researchers gain valuable insights into the metabolic perturbations associated with these diseases, potentially leading to the identification of novel biomarkers and the development of personalized therapeutic approaches. Furthermore, we provide a comprehensive overview of various mass spectrometry approaches utilized in blood metabolomics research, including GC-MS, LC-MS, and others discussing their advantages and limitations. To enhance the scope, we propose including recent review articles supporting the applicability of GC×GC-MS for metabolomics-based studies. This addition will contribute to a more exhaustive understanding of the available analytical techniques. The Integration of mass spectrometry-based blood profiling into clinical practice holds promise for improving disease diagnosis, treatment monitoring, and patient outcomes. By unraveling the complex metabolic alterations associated with non-cancer diseases, researchers and healthcare professionals can pave the way for precision medicine and personalized therapeutic interventions. Continuous advancements in mass spectrometry technology and data analysis methods will further enhance the potential of blood metabolomics profiling in non-cancer diseases, facilitating its translation from the laboratory to routine clinical application.

1 September 2014 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
AOA. A. Ostroushko
A. A. Ostroushko
IGI. F. Gette
I. F. Gette
IDI. G. Danilova
I. G. Danilova
Elena Arturovna MukhlyninaElena Arturovna Mukhlynina
Elena Arturovna Mukhlynina
MTMargarita Tonkushina
Margarita Tonkushina
KGKirill Grzhegorzhevskii
Kirill Grzhegorzhevskii
The fundamental possibility of transporting polyoxometalate with a Mo72Fe30keplerate structure through the skin of animals (rats) is shown; the efficiency of such transport significantly increases...

1 September 2013 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
AOA. A. Ostroushko
A. A. Ostroushko
IGI. F. Gette
I. F. Gette
SMS. Yu. Medvedeva
S. Yu. Medvedeva
IDI. G. Danilova
I. G. Danilova
Elena Arturovna MukhlyninaElena Arturovna Mukhlynina
Elena Arturovna Mukhlynina
MMM. V. Morozova
M. V. Morozova
There were no significant deviations from the norm in the functional state of the liver, kidneys, and pancreas in the study of the acute toxicity of iron-molybdenum buckyballs intended for targeted drug delivery. No accumulation of nanoparticles or deviation from the norm in any investigated parameter was detected in the study of subacute toxicity.

16 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
PKPavel Khramtsov
Pavel Khramtsov
AMArtem Minin
Artem Minin
ZGZarina Galaeva
Zarina Galaeva
Elena Arturovna MukhlyninaElena Arturovna Mukhlynina
Elena Arturovna Mukhlynina
MNMaria Nikitina
Maria Nikitina
Mikhail RayevMikhail Rayev
Mikhail Rayev
One of the emerging trends in modern analytical and bioanalytical chemistry involves the substitution of enzyme labels (such as horseradish peroxidase) with nanozymes (nanoparticles possessing enzyme-like catalytic activity). Since enzymes and nanozymes typically operate through different catalytic mechanisms, it is expected that optimal reaction conditions will also differ. The optimization of substrates for nanozymes usually focuses on determining the ideal pH and temperature. However, in some cases, even this step is overlooked, and commercial substrate formulations designed for enzymes are utilized. This paper demonstrates that not only the pH but also the composition of the substrate buffer, including the buffer species and additives, significantly impact the analytical signal generated by nanozymes. The presence of enhancers such as imidazole in commercial substrates diminishes the catalytic activity of nanozymes, which is demonstrated herein through the use of 3,3′-diaminobenzidine (DAB) and Prussian Blue as a model chromogenic substrate and nanozyme. Conversely, a simple modification to the substrate buffer greatly enhances the performance of nanozymes. Specifically, in this paper, it is demonstrated that buffers such as citrate, MES, HEPES, and TRIS, containing 1.5–2 M NaCl or NH4Cl, substantially increase DAB oxidation by Prussian Blue and yield a higher signal compared to commercial DAB formulations. The central message of this paper is that the optimization of substrate composition should be an integral step in the development of nanozyme-based assays. Herein, a step-by-step optimization of the DAB substrate composition for Prussian Blue nanozymes is presented. The optimized substrate outperforms commercial formulations in terms of efficiency. The effectiveness of the optimized DAB substrate is affirmed through its application in several commonly used immunostaining techniques, including tissue staining, Western blotting assays of immunoglobulins, and dot blot assays of antibodies against SARS-CoV-2.

1 September 2015 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
IDI. G. Danilova
I. G. Danilova
IGI. F. Gette
I. F. Gette
SMS. Yu. Medvedeva
S. Yu. Medvedeva
Elena Arturovna MukhlyninaElena Arturovna Mukhlynina
Elena Arturovna Mukhlynina
MTMargarita Tonkushina
Margarita Tonkushina
AOA. A. Ostroushko
A. A. Ostroushko
The effect of nanocluster iron-molybdenum polyoxometallates (POMs) on the content of histone proteins and heat shock proteins in rat blood and liver after single and repeated administration had been i